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Background: The antiviral mechanisms are not known in mESCs.
Results:mESCs are susceptible to viral infections and dsRNA-inhibited cell proliferation but do not express type I interferons.
Conclusion:mESCs have underdeveloped mechanisms for type I interferon expression.
Significance: The findings are important for understanding the development of antiviral mechanisms in ESCs and stem cell
physiology.
Embryonic stem cells (ESCs) are considered to be a promising
cell source for regenerativemedicine because of their unlimited
capacity for self-renewal and differentiation. However, little is
known about the innate immunity in ESCs and ESC-derived
cells. We investigated the responses of mouse (m)ESCs to three
types of live viruses as follows: La Crosse virus, West Nile virus,
and Sendai virus. Our results demonstrated mESCs were sus-
ceptible to viral infection, but they were unable to express type I
interferons (IFN and IFN, IFN/), which differ from fibro-
blasts (10T1/2 cells) that robustly express IFN/ upon viral
infections. The failure of mESCs to express IFN/ was further
demonstratedby treatmentwithpolyIC, a synthetic viral dsRNA
analog that strongly induced IFN/ in 10T1/2 cells. Although
polyIC transiently inhibited the transcription of pluripotency
markers, the stem cell morphology was not significantly
affected. However, polyIC can induce dsRNA-activated protein
kinase in mESCs, and this activation resulted in a strong inhibi-
tion of cell proliferation. We conclude that the cytosolic recep-
tor dsRNA-activated protein kinase is functional, but themech-
anisms that mediate type I IFN expression are deficient in
mESCs. This conclusion is further supported by the findings
that the major viral RNA receptors are either expressed at very
low levels (TLR3 andMDA5) ormay not be active (retinoic acid-
inducible gene I) in mESCs.
Embryonic stem cells (ESCs)3 have attracted enormous
attention in recent years with the expectation that they will be
used as a source for cell-based therapy. Although the benefit of
this research inmedical applications is exciting, currently there
is limited understanding of the basic physiology of ESCs and
their derived cells. When used for cell therapy, ESC-derived
cells would be placed in a wounded area that is likely to be
exposed to various pathogens. Therefore, their fate and func-
tionality may depend on their innate immunity to deal with a
hostile environment. However, it is not clear whether ESCs and
ESC-derived cells have functional innate immunity.
Derived from an early stage embryo, ESCs can divide contin-
uously under proper culture conditions. When induced, they
can differentiate into different cell lineages, a property known
as pluripotency (1, 2). Study of the molecular mechanisms that
control ESC differentiation, pluripotency, and self-renewal has
been the center of ESC research. Recent studies have led to the
development of methods for ESC differentiation into different
cell types. However, it is increasingly clear that generating clin-
ically usable cells is a task that faces many biological and tech-
nical challenges. For instance, it is well recognized that if ESCs
are not fully differentiated and transplanted to the patient, they
can grow into tumor-like structures known as teratomas (3).
However, there are many other concerns that have not been
fully recognized. An outstanding issue is the cellular innate
immunity, which is not easily recognized in the cells that are not
challenged by infectious agents. This concern is illustrated with
the case of ESC-derived endothelial cells. These cells have been
well characterized with respect to the endothelial cell marker
expression, morphology, and the ability to form vessels (4, 5).
However, only a few studies (6–8), including our own (9), have
investigated their innate immune and inflammatory responses.
Such studies have demonstrated that ESC-endothelial cells,
derived from both human andmouse ESCs (hESC andmESCs),
have limited, if any, ability to respond to lipopolysaccharides
and inflammatory cytokines. Apparently, the failure of in vitro
ESC-differentiated cells to acquire active innate immunity
could be a concern for clinical applications.
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Cellular innate immunity is mediated by pattern recognition
receptors that include toll-like receptors (TLRs) and retinoic
acid-inducible gene I (RIG-I)-like receptors. TLRs are localized
on the cell surface or on the membrane of endosomes where
they detect a wide variety of molecules that evoke immune
responses, known as pathogen-associated molecular patterns
(10). RIG-I-like receptors, including RIG-I and MDA5 (mela-
noma differentiation-associated gene 5), reside in the cytosol
and primarily recognize viral RNA (11). Upon binding with
their ligands, these receptors activate signaling pathways,
including interferon regulatory factor and nuclear transcrip-
tion factor-B (NF-B), which coordinately regulate the
expression of type I interferons (IFN/) and pro-inflamma-
tory cytokines that participate in antiviral responses (10, 12).
Another important molecule that mediates the effects of
dsRNA in the cytosol is dsRNA-activated protein kinase (PKR).
In addition to selectively activating the transcription of genes
involved in the immune responses, PKR also causes a general
inhibition of transcription, translation, and host cell prolifera-
tion that limits viral replication (13, 14). Although extensive
studies have been conducted in differentiated cells, only a few
studies have investigated the innate immunity in ESCs. It is
speculated that ESCs, normally residing in the sterile environ-
ment of the womb, may not have active innate immunity (15).
In line with this notion, recent studies indicated that hESCs do
not respond to a wide range of infectious agents, including bac-
terial LPS and dsRNA (6, 16). Similar to hESCs, it was shown
thatmESCs did not respond to LPS (7) or even live bacteria (17).
However, the molecular mechanisms involved have not been
elucidated.
In this study, we demonstrated thatmESCs are susceptible to
viral infections anddsRNA-inhibited cell proliferation, but they
are unable to express type I IFN. We provided molecular basis
for the underdeveloped antiviral mechanisms in mESCs.
EXPERIMENTAL PROCEDURES
mESC Culture—D3 cells, a commonly used mESC line in the
literature (18), were obtained from the ATCC. They were used
for themajority of the experiments in this study. The key exper-
iments were repeated in DBA252 mESCs that we previously
characterized (19–21). Both cell lines were maintained in the
standard mESC medium (21). Raw 264.7 (Raw) and 10T1/2
cells were cultured in DMEM that contains 10% fetal calf
serum, 100 units/ml penicillin, and 100 g/ml streptomycin.
All cells were maintained at 37 °C in a humidified incubator
with 5% CO2.
Preparation ofViral Stocks—LaCrosse virus (LACV, SM6v3)
andWest Nile virus (WNV, strain CT2741) were propagated in
Vero cells (African green monkey kidney cell line, ATCC).
Titers of virus stocks were determined by plaque assay as
described previously (22). Sendai virus (SeV, Cantell strain)
stock was purchased from Charles River laboratory.
Cell Treatment—mESCs and 10T1/2 were plated at40 and
70% confluence, respectively, and cultured for 24 h before the
experiments. For viral infection, viral stocks were added to the
cell culture at the concentrations as specified in individual
experiments. PolyIC (Sigma) was either directly added to the
cell culture or was transfected into the cells with DharmaFECT
reagent (Thermo Scientific). For polyIC transfection experi-
ments, control cells were transfected with DharmaFECT rea-
gent only. The culture medium and treated cells were collected
at different time periods and used for various analyses.
Real Time Quantitative-PCR (RT-qPCR)—Total RNA was
extracted using TRI Reagent (Sigma). cDNA was prepared by
Moloney murine leukemia virus reverse transcriptase (Sigma).
RT-qPCR was performed using SYBR Green ready mix on an
MX3000PTM RT-PCR system (Stratagene), as reported previ-
ously (21). The mRNA level from RT-qPCR was calculated
using the comparative Ct method (23). -Actin mRNA was
used as a calibrator for the calculation of relative mRNA of the
tested genes. The sequences of the primer sets are listed in
supplemental Table 1.
IFN and Cytokine Assays—The culture medium collected
from treated cells was used to determine secreted IFN and
cytokines. IFN was quantified with an ELISA kit that detects
mouse IFN (PBL Biomedical Laboratories) according to the
manufacturer’s instruction. IL6 andTNFwere analyzedwith a
Luminex cytokine assay kit (Millipore) and determined with a
MAGPIX instrument. The data were analyzed according to the
method described by Prabhakar et al. (24).
Cell Proliferation, Viability, and Cell Cycle Analysis—Cell
proliferation was determined by colony size and by cell number
after toluidine blue staining as we described previously (25).
The absorbance at 630 nm of toluidine blue-stained cells was
measuredwith amicrotiter plate reader. The values, which cor-
relate with the number of viable cells, were used as an indirect
measurement of cell proliferation or viability. Cell cycle analysis
by flow cytometry was performed after the cells were stained
with 50 g/ml propidium iodide. The cell cycle profiles were
generated with the CFlow software (25).
Protein Analysis by Flow Cytometry—Cellular protein analy-
sis by flow cytometry was performed according to our pub-
lished method (26). Briefly, treated cells were incubated with
the antibodies against the specific proteins to be analyzed. The
cells were then incubated with secondary antibodies conju-
gated with fluorescein isothiocyanate (FITC) and examined by
anAccuri C6 flow cytometer. The fluorescence intensity, which
correlates with the protein level, was determined with the
CFlow software. In some experiments, cells were doubly
stained with propidium iodide so that the expression level of
the protein in different phases of the cell cycle could be simul-
taneously determined.
siRNA Transfection—siRNAs targeting PKR and RIG-I or
negative control siRNA (SantaCruzBiotechnology)were trans-
fected to mESCs with DharmaFECT reagent at a final concen-
tration of 100 nM. The cells were then analyzed for siRNA
knockdown efficiency or used for the experiments as specified.
Cell Lysate Preparation and Western Blot Analysis—Cells
were directly lysed with SDS sample buffer that contains 150
mMNaCl, 10mMNaF, and 0.25mMNaVO4.Western blot anal-
ysis was carried out as described previously (25).
Immunostaining Assay—Virus-infected cells were fixed with
4% paraformaldehyde for 15 min at room temperature. Cells
were washed with PBS containing 0.3% hydrogen peroxide to
block endogenous peroxidase activity for 30 min. Cells were
blocked with 2% normal goat serum with 0.4% Triton X-100
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and incubated overnight at 4 °C with affinity-purified and anti-
flavivirus envelope proteinmonoclonal antibody (4G2, ATCC).
The cells were washed with PBS and then incubated with
secondary antibodies conjugated to HRP (horseradish peroxi-
dase) for 2 h at room temperature. Positive cells were identified
using a TrueBlue detecting kit (KPL) under a phase contrast
microscope.
RESULTS
mESCs Are Susceptible to the Cytopathic Effects of LACV
Infection—To investigate the responses ofmESCs to viral infec-
tion, we first infected cells with LACV (a negative sense ssRNA
virus) that is known to cause lytic cell death ofmammalian cells
(27). 10T1/2 cells, a mouse cell line with fibroblast properties
(28), were used as a positive control. Following the infection
with LACV (m.o.i.  1), cytopathic effects were observed at
48 h post-infection in 10T1/2 cells. These effects included cell
morphological changes, such as rounding up and detachment
from the culture dish. Similar effects were observed in mESCs
at a longer incubation time (60 h) (Fig. 1A, indicated by
arrows). Viral infection of mESCs was confirmed by expression
of the LACV gene that encodes the M-segment protein (Gc
protein) (29). The infected cells were immunostainedmonoclo-
nal antibodies against the Gc protein (a gift fromDr. Samantha
Soldan, University of Pennsylvania School of Medicine) fol-
lowed by flow cytometry analysis (29). As shown in Fig. 1B, the
expression of Gc protein was detected at 30 h and was signifi-
cantly increased at 40 h post-infection.
The cytopathic effect of LACVwas proportional to viral load
as indicated by the reduced number of viable cells at different
multiplicities of infection (Fig. 1,C andD). LACV infection also
caused cell cycle inhibition as indicated by an apparent reduc-
tion of cells in the G2 phase (Fig. 1E, indicated by arrow) and a
reduced expression level of cyclin E (Fig. 1F). Therefore, the
reduced cell number ofmESCs by LACV infection could be due
to the lytic cell death as well as a general inhibition of cell pro-
liferation associated with viral infection.
mESCs Are Deficient in Expressing Type I IFN in Response to
Viral Infection—Under the normal conditions, very lowmRNA
levels of IFN and IFNwere detected in 10T1/2 cells andwere
nearly undetectable inmESCs. LACV infection induced about a
1900-fold increase of IFN in 10T1/2 at an m.o.i. of 1, but the
induction in mESCs was negligible even at an m.o.i. of 10 (Fig.
2A). In addition, LACV infection up-regulated the expression
of IFN/ and the major viral RNA receptors, including RIG-I,
PKR,MDA5, andTLR3, to different degrees in 10T1/2 cells, but
such effects were not observed in mESCs (Fig. 2A). These
results indicated that mESCs are susceptible to LACV infec-
tion, but they are unable to effectively express IFN and IFN.
To determine whether this observation is a general property
of mESC or it is an event specific to LACV infection, we tested
two additional viruses,WNV (a positive sense ssRNAvirus) and
SeV (a negative sense ssRNA virus). In both cases, viral infec-
tion induced a large increase of IFN transcription in 10T1/2
cells, but induction in mESCs was less than 5-fold (Fig. 2, B and
C). Viral infectivity in both mESCs and 10T1/2 cells was con-
firmed by expression of viral proteins. WNV E glycoprotein
(30) was detected with monoclonal antibodies (4G2, ATCC) by
FIGURE 1. Infection of mESCs and 10T1/2 cells with LACV. A, mESCs (D3)
and 10T1/2 cells were infected with LACV (m.o.i.  1). The cells were exam-
inedunder aphase contrastmicroscopeandphotographed (400) at 48h for
10T1/2 cells and 60 h for D3 cells. Arrows denote detaching dead cells.
B, detection of LACVGc protein in D3 cells infectedwith LACV (m.o.i. 10) by
flow cytometry. The expression level was proportional to fluorescence (Flu)
intensity. C, D3 and 10T1/2 cells were infected with LACV at an m.o.i. of 1.
Viable cells were determined at 48 h post-infection by toluidine blue cell
staining. The values are means  S.D. of a representative experiment per-
formed in biological triplicates. D, D3 cells were infected with LACV at a dif-
ferent m.o.i. as indicated. Viable cells were determined at 48 h post-infection
as described in C. E, D3 cells were infected with LACV (m.o.i.  10). The cell
cycle profiles and cell count were determined with CFlow software. Reduc-
tion of the G2 phase cells was indicated by the arrow. F, cyclin E expression
level in LACV-infected D3 cells described in E (40 h) was determined by flow
cytometry. The control (Con) represents cellswithout viral infection.All exper-
iments were performed at least twice with similar results.
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immunostaining (Fig. 2B, inset), whereas SeV nucleocapsid
protein (31) was detected by RT-PCR analysis (Fig. 2C, inset).
AlthoughWNV or SeV infection caused a slight but consistent
inhibition of cell proliferation, they did not cause apparent lytic
cell death as LACV (data not shown).
mESCsCan Sense andRespond to dsRNA viaCytosolic Recep-
tors but Fail to Produce Functional IFN and IL6—We further
analyzed the responses of mESCs to polyIC, a synthetic analog
of viral dsRNA that is widely used to mimic viral infection (32).
When directly added to the cell culture, polyIC is expected to
bind to TLR3 at the cell surface or to be internalized into the
endosomes where it activates TLR3 (33, 34). This was demon-
strated in Raw cells where polyIC induced the expression of
IFN and IFN, but not in mESCs (data not shown), indicating
that mESCs may not have functional TLR3 and/or a functional
mechanism for polyIC internalization. However, when trans-
fected into cells, polyIC can induce a several-fold increase of the
transcription of three types of molecules typically seen in anti-
viral responses as follows: type I IFN (IFN/), inflammatory
cytokines (TNF and IL1), and the cell adhesion molecule
(VCAM1) in D3mESCs (Fig. 3A). Similar results were obtained
in another line of mESCs, DBA252 (Fig. 3B). These results
imply that mESCs can sense and respond to dsRNA via cyto-
plasmic receptors. However, the induction of IFN in mESCs
was negligible when compared with 10T1/2 cells, whereby
polyIC induced nearly a 4000-fold increase of IFN mRNA.
PolyIC-induced transcription of IL6 and ICAM1 was also sub-
stantially higher in 10T1/2 cells than inmESCs (Fig. 3C).When
examined at the protein level by ELISA, neither IFN nor IL6
was detected in the media collected from polyIC-transfected
mESCs, although they were readily detected in the samples
from Raw cells and 10T1/2 cell cultures (Fig. 3D). Similar
results were obtained for TNF (data not shown). Similarly,
ICAM1 protein was induced by polyIC transfection in 10T1/2
cells, but not in mESCs, as analyzed by flow cytometry of the
cells immunostained with anti-ICAM1 antibodies (Santa Cruz
Biotechnology) (Fig. 3E). Therefore, transfected polyIC could
elicit a limited increase of transcripts of the above mentioned
immunemediators inmESCs, but their corresponding proteins
were not detected.
PolyIC Transfected to mESCs Inhibits Cell Proliferation—
The most notable effect of transfected polyIC on mESCs at the
cellular level was the inhibition of cell proliferation. As shown
in Fig. 4, the colonies of polyIC-transfected cells were much
smaller than the control colonies (Fig. 4A), correlating with
markedly reduced cell numbers (Fig. 4B). In control cells, about
60% of cells were in the S phase, but polyIC caused an apparent
reduction of cells in the S and G2/M phases (Fig. 4C, indicated
by arrow and arrowhead, respectively). A time course analysis
revealed that the effects of polyIC can be detected as early as 6 h
(Fig. 4D). It is noted that polyIC transfection also caused a small
number of apoptotic cells (floating cells, data not shown),
FIGURE 2. Viral infection-induced expression of IFN and IFN in D3 and
10T1/2 cells. A, 10T1/2 and D3 cells were infected with LACV at anm.o.i. of 1
and 10, respectively. The mRNA levels of the tested genes were determined
by RT-qPCR 24 h post-infection. B, 10T1/2 and D3 cells were infected with
WNV at an m.o.i. of 5 and 10, respectively. The mRNA levels of IFN and IFN
were determined by RT-qPCR 24 h post-infection (graph). Infected cells were
immunostained with antibodies against WNV E glycoprotein, and immuno-
positive cells were stained dark blue (inset). C, 10T1/2 and D3 cells were
infectedwith SeV at 300hemagglutination units/ml. ThemRNA levels of IFN
were determined by RT-qPCR 12 and 24 h post-infection (graph). The tran-
scription of SeV nucleocapsid protein in infected cells was determined by
RT-PCR and analyzed by agarose gel electrophoresis. -Actin was used as a
loading control (inset). All results shown in the graphs are expressed as fold
activation, where the mRNA level in control cells is designated as 1 (not
shown). The values aremeans S.D. of three independent experiments. The
experiments shown in the insetswere performed twice with similar results.
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which may also contribute to the reduced cell number and col-
ony size.
Because the constitutive activation of CDK2 by cyclin A and
E is the key factor that drives the rapid cell proliferation in
mESCs (35), we examined the effects of polyIC on the expres-
sion of these cell cycle regulators. The reduced expression of
cyclin E was apparent at 6 h after treatment, and this trend
lasted for 24 h, as determined with its antibodies (Santa Cruz
Biotechnology) by flow cytometry (Fig. 4E). Although cyclin A
was not affected at 6 and 12 h, it was reduced at 24 h. A similar
patternwas also demonstrated in the expression levels of CDK1
and CDK2 (data not shown). The CDKIs, including p16, p19,
and p21, are expressed at very low levels in control cells, and
polyIC did not affect their expression (data not shown). These
results suggest that down-regulation of cyclin E, and to a lesser
extent cyclin A, CDK1, and CDK2, contributed to polyIC-in-
hibited cell proliferation.
Effect of PolyIC on the StemCell State—To test if the stem cell
state ofmESCswas affected by polyIC, we examined themRNA
levels of pluripotencymarkers in polyIC-transfected cells. They
were transiently down-regulated at 6 and 12 h but recovered
nearly to the level of the controls by 24 h (Fig. 5A). In agreement
withmRNAchange, the protein level ofOCT4, a key gene in the
pluripotency control network (1), displayed a similar pattern
with an initial slight decrease but returned to the normal levels
at 24 h (Fig. 5B). Interestingly, the transcription of several early
differentiation markers showed a similar dynamic pattern (Fig.
5C) to the pluripotency markers (Fig. 5A). Because of polyIC-
induced cell cycle inhibition, the colonies formed from polyIC-
transfected cells were smaller than those formed from control
FIGURE 3. PolyIC transfected to mESCs can induce low level transcription of immune mediators but fail to produce detectable proteins. A–C, D3,
DBA252, and 10T1/2 were transfected with 300 ng/ml polyIC. mRNA was analyzed by RT-qPCR. The results are expressed as fold-activation where the mRNA
level in control cells is designated as 1. The values in A and C are means  S.D. of three independent experiments. The values in B are means  S.D. of a
representative experiment performed in biological triplicates.D,D3 and 10T1/2 were transfected with polyIC as described in A and C. For Raw cells, polyIC (25
g/ml) was directly added to the culture medium. The culture medium collected at different time points was analyzed for IFN by ELISA (detectable range
15.6–1000 pg/ml) and IL6 by Luminex assay (detectable range 0.64–10,000 pg/ml).ND, not detected. The values for IFN aremeans S.D. of a representative
experiment performed in triplicate. The values for IL6 are average of a representative experiment performed in duplicate. E, expression profiles of ICAM1 in
10T1/2and inD3cells determinedby flowcytometry. The representativeexperiments in all panelswere repeatedat least twicewith similar results.Con, control.
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cells, but their overall morphology (round with densely packed
undifferentiated cells) was not significantly changed, as exam-
ined at 40 h (as shown in Fig. 4A) or at 72 h post-transfection
(Fig. 5D).
Relative Expression Levels of dsRNA Receptors in mESCs and
10T1/2 Cells—To identify the receptor(s) that mediate the
effects of transfected polyIC, we analyzed the relative expres-
sion levels of the four dsRNA receptors. The mRNA level of
each molecule was determined by RT-qPCR and compared
with that of -actin. In D3 cells, TLR3 is expressed at a very low
level, and MDA5 is barely detected, although RIG-I and PKR
are expressed at higher levels (Fig. 6A). A similar pattern was
seen in DBA252 cells (Fig. 6B). When compared with 10T1/2
cells, the mRNA of TLR3 and MDA5 in D3 cells are negligible,
although RIG-I is about one-third of that in 10T1/2 cells. How-
ever, PKR is expressed at similar levels in the two types of cells
(Fig. 6C).
PKR Plays a Key Role in Mediating the Effects of PolyIC in
mESCs—The higher basal expression levels of PKR and RIG-I
in mESCs make them the likely candidates that mediate the
effects of polyIC. We first investigated PKR by its ability to
phosphorylate eukaryotic initiation factor 2 (eIF2). It is
known that phosphorylation of eIF2 by PKR attenuates its
function in translation, thereby resulting in protein synthesis
inhibition (13). PolyIC indeed stimulated eIF2 phosphoryla-
tion in mESCs as determined by flow cytometry and confirmed
by Western blot analysis using antibodies that specifically rec-
ognize phosphorylated eIF2 (p-eIF2, Cell Signaling),
although the expression of PKR did not change significantly.
p-eIF2 was detected as early as 30 min after polyIC transfec-
tion (Fig. 7A, boxed areas), which preceded cell cycle inhibition.
Pretreatment of the cells with a PKR inhibitor C16 (Sigma)
blocked polyIC-induced eIF2 phosphorylation (data not
shown), indicating that PKR is the responsible kinase. These
FIGURE 4.Effects of polyIConmESC colony formationand cell proliferation.A–C,D3 cellswere transfectedwith 300ng/ml polyIC. Control (Con) represents
cells transfected with DharmaFECT without polyIC. After incubation for 40 h, the colonies were examined under a phase contrast microscope and photo-
graphed with a digital camera (100, upper panels; 400, lower panels) (A). Cell proliferation was measured by cell number indirectly determined from
toluidine blue staining (absorbance at 630 nm). The values aremeans S.D. of an experiment performed in biological triplicate (B). Cell cycle was analyzed by
flowcytometry. The cell cycle profiles and cell countweredeterminedwith a computer software. Reductionof the S andG2/Mphase cellswere indicatedby the
arrowandarrowhead, respectively (C).D,D3cellswere transfectedwithpolyIC and incubated for the times as indicated. The cell cycleprogressionwas analyzed
by flow cytometry as described in C. E, effect of polyIC on cyclin E expression was determined by flow cytometry after immunostaining of the cells with
antibodies against cyclin E. All representative experiments were performed at least twice with similar results.
mESCs Are Deficient in Type I IFN Expression
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results were confirmedwith siRNA targeting PKR,which atten-
uated eIF2 phosphorylation, although the negative control
siRNA had no effect (Fig. 7B, upper panels, boxed areas).
Importantly, silencing PKR reversed polyIC-induced reduction
of S and G2/M phase cells (Fig. 7B, middle panels) as well as
reduced colony size (Fig. 7B, lower panels). However, knocking
down RIG-I did not show such effects. These data demonstrate
that PKR, not RIG-I, plays a key role in mediating polyIC-in-
duced cell cycle inhibition.
We then analyzed the effects of silencing PKR and RIG-I on
polyIC-induced transcription of IFN and IL6. siRNA targeting
PKR and RIG-I specifically knocked down their targets as
expected (Fig. 7C). Silencing PKR significantly reduced mRNA
levels of both IL6 and IFN, whereas silencing RIG-I slightly
attenuated transcription of IL6 but not that of IFN (Fig. 7D).
PKR Is Activated by LACV but Not by WNV or SeV Infection
in mESCs—We analyzed whether or not PKR was activated in
virus-infected cells. As shown in Fig. 8A, a time course study of
LACV-infected cells indicated PKR was activated at 11 h post-
infection and lasted up to 30 h as indicated by eIF2 phosphor-
ylation, although the protein level of PKR was not altered as
determined by Western blot with PKR antibodies (Santa Cruz
Biotechnology). Knocking down PKR expression did not have
an apparent effect on LACV-induced cell death (Fig. 8B). Sim-
ilar results were obtained in the experiments with the C16 PKR
inhibitor (data not shown). PKR activation by LACV was fur-
ther confirmed by flow cytometry with antibodies against
p-eIF2; however, p-eIF2 was not detected in the cells
infected with WNV or SeV in parallel experiments (Fig. 8C).
These results suggested that PKR activation is virus-dependent
in mESCs.
DISCUSSION
In this study, we investigated the responses of mESC to three
types of live viruses and two synthetic viral dsRNA analogs.
Althoug all of these stimuli induced a robust IFN/ expression
in 10T1/2 cells, they only induced very limited or no detectable
transcription of IFN/. These results suggest that mESCs are
deficient in type I IFN expression, a central component of the
antiviral mechanisms in most types of somatic cells.
It is known that many viruses have developed certain mech-
anisms to avoid the host antiviral responses. Repressing
IFN/ induction in host cells is one such mechanism (36).
However, the capacity of these viruses to repress IFN/ induc-
tion seems to depend on the types of host cells, as we demon-
strated in 10T1/2 cells in which LACV can induce strong tran-
scription of Ifn/ as well as the key components involved in
IFN/ expression, such as Rig-I,Mda5, and Tlr3. The induc-
tion of IFN by WNV and SeV in 10T1/2 cells was also signif-
icant. Therefore, the failure to express IFN/ in mESCs is not
virus-specific or due to the IFN evasion strategies of viruses.
This conclusion is in line with the observations recently
reported by Wash et al. (37) that herpes simplex virus type I
(HSV-1, a DNA virus) and influenza virus (a negative sense
ssRNA virus) caused cytopathic effects without evoking type I
IFN induction. Together with results from the experiments
with polyIC and 3p-ssRNA,4 which mimic viral RNA in induc-
ing a robust IFN/ expression in 10T1/2 cells but not in
mESCs, we conclude that deficiency in type I IFN expression is
an intrinsic property of mESCs.
We have provided the molecular basis that explains the
defective IFN/ expression in mESCs. In some cell types,
polyIC can induce IFN/ via activation of TLR3 at the cell
surface or in the endosomes (11, 38, 39).When transfected into
the cells, polyIC can induce robust IFN/ expression and
4 R. Wang, F. Huang, and Y.-L. Guo, unpublished data.
FIGURE 5. Effects of polyIC on the expression of pluripotency/differenti-
ationmarkers and cell/colonymorphology ofmESCs.D3 cells were trans-
fected with 300 ng/ml polyIC and incubated for a time course of 24 h. The
mRNA levels of pluripotencymarkers (A) and early differentiationmarkers (C)
were determined by RT-qPCR. The results are means  S.D. of three inde-
pendent experiments. The effect of polyIC on the protein level of Oct 4 was
determined by flow cytometry. 1st AB represents the experiments where
the cells were not incubatedwith anti-Oct4 antibodies (1st antibodies) as the
control (B). The effect of polyIC on cell/colony morphology was examined
under a phase contrast microscope and photographed with a digital camera
at 72 h after treatment (400). The images are representative experiments
performed at least three times (D). Con, control.
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other responses that are similar to those evoked by viral infec-
tion via cytoplasmic dsRNA receptors (32, 40). mESCs were
unresponsive to polyIC that was directly added to the medium,
likely due to the very low level expression of TLR3. However,
polyIC transfected into the mESCs showed a profound inhibi-
tory effect on proliferation, a known effect of polyIC on many
types of differentiated cells, indicating that the cytoplasmic
receptors for polyIC are active in mESCs.
One of the distinctive features of mESCs is their rapid cell
proliferation that is driven by constitutively active Cdk2-cyclin
A/E complexes (41, 42). It is conceivable that actively dividing
mESCs are more sensitive to polyIC-inhibited translation
because cell proliferation critically depends on de novo protein
synthesis. We had expected that polyIC-inhibited cell prolifer-
ation could significantly affect their stem cell state. However,
morphology of the individual cells and colonies appeared to be
maintained at the undifferentiated state despite their transient
decrease in transcription of pluripotency markers. Because
polyIC caused similar changes to the transcription of differen-
tiationmarkers, the effect is not gene-specific, but rather a gen-
eral transcription disturbance similar to that caused by viral
infection (13). We speculate that the nonspecific transcription
interferencemight helpmESCsmaintain their stemcell state by
preventing the expression of genes that promote differentia-
tion, at least for a short period of time under our experimental
conditions. PolyIC-induced cell cycle inhibition is transient
because polyIC-treated cells can resume a normal rate of pro-
liferation in subculture when they were passed to new culture
dishes. Thus, the transient change of pluripotency and differ-
entiation markers is not surprising because the experiments
were performed in the presence of leukemia inhibitory factor,
which maintains the pluripotency and prevents differentiation
of mESCs. This observation is in line with our recent study
demonstrating that transient inhibition of cell proliferation
does not compromise the stem cell state of mESCs (26).
It is generally believed that MDA5 and RIG-I play primary
roles inmediating viral RNA-induced IFN/ expression in the
cytoplasm (11, 39), although PKR also contributes to and mod-
ulates this process (13, 14). Because MDA5 is expressed at a
negligible level in mESCs, it is conceivable that PKR and/or
RIG-I may mediate the effects of transfected polyIC. However,
the RIG-I signaling pathway seems to be inactive because
silencing RIG-I did not affect the effects of polyIC and because
3p-ssRNA (5-triphosphate single-stranded RNA), the best
studied ligands of RIG-I (43, 44), failed to induce IFN in
mESCs. Nevertheless, substantial evidence indicates that PKR
plays a key role in mediating the effects of polyIC, as demon-
strated by the phosphorylation of eIF2 and the results
observed in the PKR silencing experiments. It is known that
IFN-induced activation of ribonuclease L (RNase L) can hydro-
lyze both cellular and viral RNA (14). Although polyIC could
lead to RNase L activation in some cells (45), this does not seem
to be the case in mESCs because polyIC did not cause rRNA
degradation (data not shown), which is a commonly used indi-
cator of RNase L activation (45). The result further supports our
conclusion that polyIC could not induce a sufficient level of
IFN/ in mESCs for RNase L activation.
LACV infection also activated PKR in mESCs, similar to the
finding in murine embryonic fibroblasts (46). However, silenc-
ing or inhibition of PKR did not significantly affect LACV-in-
duced cell death ofmESCs, which is in linewith the observation
that PKRactivation has little impact on viral replication as dem-
onstrated in PKR/ murine embryonic fibroblasts (46). PKR
activation has been implicated in apoptosis, but its roles are
stimulus- and virus-dependent (47). The effects of PKR activa-
tion by LACV on mESCs could be more complex than polyIC
due to the fact that many other cellular and viral factors are
involved during infection. Unlike LACV infection, we did not
detect PKR activation in themESCs infectedwithWNVor SeV.
Failure to activate PKR by these viruses has been noted in other
cells. As recently reported in rodent cells, WNV infection does
not induce PKR activation, possibly by a mechanism that
sequesters viral dsRNA from host PKR (48). In the case of SeV,
it is proposed that PKR activation is repressed by the C protein
encoded by the virus (49). Whether or not these mechanisms
are utilized in mESCs remains to be investigated.
It is interesting to note that hESCs do not express IFN/
even at the mRNA level when transfected with polyIC (6, 16).
mESCs can express limited transcripts of Ifn/, Il6, and
Icam1, but they could not produce detectable levels of their
respective proteins. Thus, the transcription of these immune
mediators in mESCs may have limited function, if any, as an
antiviral mechanism. In speculating the physiological signifi-
cance of dsRNA-induced cellular events in ESCs, it is worth
mentioning that in differentiated cells, dsRNA can be formed
under some circumstances, but they are retained in the nucleus
for editing and rarely exported to the cytoplasm (50). However,
the nuclear retention mechanism in ESCs is less effective. As a
result, dsRNAs may be exported to the cytoplasm in ESCs
where they activate dsRNA receptors (51). In addition, other
FIGURE 6. RelativemRNA levels of dsRNA receptors inmESCs and 10T1/2 cells. ThemRNA levels of dsRNA receptors in D3 (A), DBA252 (B), and 10T1/2 (C)
weredeterminedbyRT-qPCR. Their relative abundance in each cellwas determinedby comparingwith themRNA level of-actin (designated as 1). For a direct
comparison, the relative mRNA level of each molecule in D3 cells and 10T1/2 cells is presented in C. The results are means  S.D. of three independent
experiments in all panels.
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types of abnormal RNAs, such as those derived from cell death
or from RNA processing, could activate PKR (52, 53). In partic-
ular, PKR is considered to be a “sentinel kinase for stress” for its
involvement in stress response in addition to antiviral response
(54). Therefore, it appears that dsRNA-induced inhibition of
translation and cell proliferation in mESCs could be an impor-
FIGURE 7. PKR plays key roles in mediating the effects of polyIC. A, polyIC-induced phosphorylation of eIF2. D3 cells were transfected with 300 ng/ml
polyIC and incubated for the times indicated. The cells with phosphorylated eIF2 (p-eIF2) were quantified by flow cytometry (boxed areas).White slash lines
were used to help identify the bottom sides of the boxes). The blot insets illustrate the levels of p-eIF2 and PKR determined byWestern blot. Actin was used
as a loading control. B, effects of PKR and RIG-I silencing on polyIC-induced cellular events. D3 cells were transfected with siRNA against PKR (siPKR), RIG-I
(siRIG-I), or negative control siRNA (siNeg) for 24 h. The cells were split into new dishes. After 24 h, the cells were transfected with polyIC for 24 h and analyzed
for p-eIF2 by flow cytometry (upper panels), cell cycle by flow cytometry (middle panels, the changes in S and G2/M phase cells are indicated by the arrow and
arrowhead, respectively), and cell proliferation/colony formation by microscopy (lower panels). C and D, relative contributions of PKR and RIG-I to polyIC-
induced mRNA of IL6 and IFN. D3 cells were transfected with siPKR, siRIG-I, or negative control siRNA followed by polyIC treatment as described in B. The
mRNA levels of PKRandRIG-I (C) or IL6 and IFN (D)weredeterminedbyRT-qPCRand comparedwith themRNA in the cells thatwere transfectedwithnegative
control siRNA (defined as 1) in each group. The results are means  S.D. of three independent experiments. The difference is considered to be statistically
significant when p 0.05 (*). All representative experiments in A and Bwere performed at least twice with similar results.
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tant mechanism that helps cells deal with immunogenic
stresses.
In summary, our study demonstrates that expression of type
I IFN as a crucial part of antiviral responses is underdeveloped
in mESCs. Our study may open up an important area in ESC
research for understanding the development of antiviral mech-
anisms during embryogenesis and how the stress caused by
immunogenic signals affects ESC physiology.
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